Casablanca: MASI steady as Managem leads after 147% Q1 revenue jump
The MASI rose 0.16% to 18,448.3 points on May 18, while the MASI 20 fell 0.32% to 1,331.43 and the MASI ESG gained 1.13% to 1,322.34. After a 1.74% weekly drop as of May 15, miners moved back into focus as Managem posted a 147% jump in first-quarter revenue on the back of the Boto and Tizert projects, according to Boursenews and Zonebourse. Managem also became the market's largest capitalization, overtaking Attijariwafa Bank, La Vie éco reported, while Unimer jumped 6% to MAD 167.45 on May 18 despite a near-flat benchmark, according to an analyst note. In consumer names, Label Vie posted solid first-quarter sales, according to L'Economiste, as the sector stayed active with the Label'Vie-Retail Holding merger detailed by Telquel.ma and CMGP Group's completed acquisition of CPCM, AgriMaroc.ma reported.
Related stories
MASI falls 0.83% as Label Vie and SMI post double-digit growth
The MASI fell 0.83% to 18,113.11 points on May 20, while the MASI 20 dropped 1.08% to 1,306.24 and the MASI Mid and Small Cap index lost 0.94% to 1,864.77. On the corporate front, Label Vie posted first-quarter 2026 revenue of 4.18 billion dirhams, up 15.9% at end-March, according to Le Matin.ma, Medias24 and L'Economiste. SMI reported a 36% jump in first-quarter revenue, driven by soaring silver prices, according to Medias24. Some stocks outperformed the weaker market, with AGM up 5.6% on May 20 after Promopharm gained 5.9% on May 19 and Unimer rose 6% to 167.45 dirhams on May 18, according to Casablanca Stock Exchange notes.
Casablanca Stock Exchange — AGM Jumps 5.6% Even as MASI Falls 0.83%
AGM posted one of the day’s standout gains on the Casablanca Stock Exchange, rising 5.6% to MAD 7,250 in a market dominated by declines. The MASI fell 0.83%, dragged by banks and industrial names, while a handful of mid-caps proved more resilient.
Casablanca Stock Exchange — Promopharm Jumps 5.9% Even as MASI Falls 1.0%
Promopharm posted the day’s best gain, rising 5.9% to MAD 1,346 while the MASI fell 1.0%. Mining losses and FX pressure drove the broader selloff, but pharmaceutical names showed unusual resilience.